会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • ISOLATING METHOD FOR UMBILICAL CORD BLOOD-DERIVED PLURIPOTENT STEM CELLS EXPRESSING ZNF281
    • 用于表达ZNF281的脐带血衍生的PLUIPOTETE STEM细胞的分离方法
    • US20120021509A1
    • 2012-01-26
    • US13257961
    • 2010-03-03
    • Kyung Sun KangKyoung Hwan Roh
    • Kyung Sun KangKyoung Hwan Roh
    • C12N5/0789
    • The present invention relates to a method for isolating pluripotent/multipotent stem cells derived from umbilical cord blood, characterized by culturing monocytes isolated from umbilical cord blood in a culture vessel containing fibronectin and then harvesting stem cells from the culture, the umbilical cord blood-derived pluripotent/multipotent stem cells isolated thereby; and a cell therapeutic agent containing the pluripotent/multipotent stem cells derived from umbilical cord blood or cells differentiated therefrom. The present invention also relates to a novel culture media for stem cells, a culture method for stem cells which is characterized by culturing and proliferating stem cells in the culture media, and a method for increasing stemness of stem cells which is characterized by a sphere culture or a three-dimensional culture of stem cells.
    • 本发明涉及一种用于分离源自脐带血的多能/多能干细胞的方法,其特征在于在含有纤粘连蛋白的培养容器中培养从脐带血分离的单核细胞,然后从培养物中收获干细胞,脐带血衍生 由此分离的多能/多能干细胞; 以及含有衍生自脐带血的多能/多能干细胞或与其分化的细胞的细胞治疗剂。 本发明还涉及用于干细胞的新型培养基,干细胞的培养方法,其特征在于培养培养基中培养和增殖干细胞,以及提高干细胞干细胞的方法,其特征在于球培养 或干细胞的三维培养。
    • 5. 发明申请
    • Method For Isolation of a Hair Follicle Stem Cell and a Composition For Hair Reproduction
    • 用于分离毛囊干细胞的方法和用于头发繁殖的组合物
    • US20080286243A1
    • 2008-11-20
    • US11995910
    • 2007-07-04
    • Kyung Sun KangJeong Chan Ra
    • Kyung Sun KangJeong Chan Ra
    • A61K35/12C12N5/02A61P17/14
    • C12N5/0628A61K35/12C12N2500/25C12N2500/32C12N2500/38C12N2500/90C12N2501/11C12N2501/115C12N2501/599C12N2501/70
    • The present invention relates to a method for isolating hair follicle stem cells and a composition for inducing hair growth. More specifically, relates to a method for isolating hair follicle stem cells showing a positive immunological response to CD34, by chemically degrading hair follicle-containing scalp tissue and then culturing the degraded tissue in a serum-containing medium and a serum-free medium, as well as a composition for inducing hair growth, which contains, as an active ingredient, CD34-positive hair follicle stem cells isolated by the method. The hair follicle-derived stem cells, which are obtained according to the disclosed method, are classified as autologous adult stem cells, have self-renewal capability, the ability to differentiate into adult hair follicle cells and the ability to induce hair growth, and can be used as a novel cell therapeutic agent against hair loss. In addition, the present invention relates to a method for culturing hair follicle cells, which has high yield compared to that of the prior art, as well as a method for identifying hair follicle stem cells.
    • 本发明涉及一种分离毛囊干细胞的方法和用于诱导毛发生长的组合物。 更具体地,涉及通过化学降解含毛囊的头皮组织然后在含血清的培养基和无血清培养基中培养所述降解组织,分离出对CD34具有阳性免疫应答的毛囊干细胞的分离方法,如 以及用于诱导毛发生长的组合物,其含有通过该方法分离的CD34阳性毛囊干细胞作为活性成分。 根据公开的方法获得的来自毛囊的干细胞被分类为自体成体干细胞,具有自我更新能力,分化成成年毛囊细胞的能力和诱导毛发生长的能力,并且可以 用作抗脱发的新型细胞治疗剂。 此外,本发明涉及培养与现有技术相比具有高产量的毛囊细胞的方法以及用于鉴定毛囊干细胞的方法。
    • 7. 发明申请
    • MULTIPOTENT ADULT STEM CELL DERIVED FROM CANINE UMBILICAL CORD BLOOD, PLACENTA AND CANINE FETUS HEART, METHOD FOR PREPARING THE SAME AND CELLULAR THERAPEUTICS CONTAINING THE SAME
    • 多发性成熟干细胞来源于犬脐动脉血,血管和INE骨心脏,其制备方法和包含其的细胞治疗方法
    • US20100021436A1
    • 2010-01-28
    • US12300281
    • 2007-05-12
    • Kyung Sun KangOh Kyung KwonYun Hyeok JeongJi Hey LimChang Soo Jung
    • Kyung Sun KangOh Kyung KwonYun Hyeok JeongJi Hey LimChang Soo Jung
    • A61K35/12C12N5/074
    • A61K35/51A61K35/34A61K35/50C12N5/0607
    • The present invention relates to multipotent adult stem cells derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart, and a method for preparing the same as well as a cellular therapeutic agent containing the same, more specifically, to a multipotent adult stem cell isolated by culturing an eukaryotic cell derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart in a FBS-containing medium and a method for preparing the same. Adult stem cells according to the present invention are derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart. The adult stem cells have characteristics highly similar to human mesenchymal stem cells as well as remarkable cell growth at the initial step compared to human UCB-derived mesenchymal stem cells so that the cells are useful to treat canine incurable diseases and difficult-to-cure diseases. Furthermore, multipotent adult stem cells are effective to treat musculoskeletal diseases and neural diseases due to the ability to differentiate into osteogenic cells and neural cells.
    • 本发明涉及来自犬脐带血的多潜能成体干细胞,来自犬胎心的胎盘血液和血液样品,以及其制备方法以及含有该成体干细胞的细胞治疗剂,更具体地,涉及多潜能 通过在含FBS的培养基中培养源自犬脐带血,胎盘血液和犬胎儿心脏的血液样品的真核细胞分离的成体干细胞及其制备方法。 根据本发明的成体干细胞衍生自犬脐带血,胎盘血和来自犬胎心的血液样品。 与人UCB来源的间充质干细胞相比,成体干细胞具有与人间充质干细胞高度相似的特征,并且在初始步骤中显着的细胞生长,使得细胞可用于治疗犬不治之症和难以治愈的疾病 。 此外,多能成体干细胞由于分化成成骨细胞和神经细胞的能力而有效治疗肌肉骨骼疾病和神经疾病。
    • 9. 发明授权
    • Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune disorders and inflammatory diseases
    • 药物组合物,其包含用NOD2激动剂或其培养物处理的用于预防和治疗免疫疾病和炎性疾病的干细胞
    • US09408873B2
    • 2016-08-09
    • US13818234
    • 2011-08-19
    • Kyung Sun KangHyung Sik Kim
    • Kyung Sun KangHyung Sik Kim
    • A61K35/28A61K35/545A61K38/05C12N5/0775
    • A61K35/28A61K35/545A61K38/05C12N5/0665C12N2501/02C12N2501/05C12N2501/052C12N2501/054
    • The present invention relates to a pharmaceutical composition for the prevention or treatment of immune disorders and inflammatory diseases, comprising stem cells that are generated by culturing stem cells expression Nucleotide-binding Oligomerization Domain protein 2 (NOD2) with a NOD2 agonist or a culture thereof. More particularly, the present invention relates to a method for suppressing immune responses or inflammatory responses of a subject, comprising the step of administering the pharmaceutical composition, the stem cells or culture thereof to the subject, a method for preparing an immunosuppressive drug or an anti-inflammatory drug using the stem cells or culture thereof, a method for preparing PGE2 or TGF-β1 comprising the step of culturing NOD2-expressing stem cells in culture medium with a NOD2 agonist, a graft comprising stem cells expressing NOD2 and the NOD2 agonist, a method for preparing the graft, a composite comprising stem cells expressing NOD2 and the NOD2 agonist, and a culture generated by culturing the NOD2-expressing stem cells with a NOD2 agonist.
    • 本发明涉及用于预防或治疗免疫疾病和炎性疾病的药物组合物,其包含通过用NOD2激动剂或其培养物培养干细胞表达核苷酸结合寡聚化结构域蛋白2(NOD2)而产生的干细胞。 更具体地,本发明涉及一种抑制受试者的免疫应答或炎症反应的方法,包括向受试者施用药物组合物,干细胞或培养物的步骤,制备免疫抑制药物或抗体的方法 使用干细胞或其培养物的炎症药物,制备PGE2或TGF-β1的方法,其包括用NOD2激动剂培养培养基中培养表达NOD2的干细胞的步骤,包含表达NOD2的干细胞的移植物和NOD2激动剂, 制备移植物的方法,包含表达NOD2的干细胞和NOD2激动剂的复合物,以及通过用NOD2激动剂培养表达NOD2的干细胞产生的培养物。